Vascular endothelial dysfunction in gestational diabetes mellitus

被引:9
作者
Lan, Qianyu [1 ]
Zhou, Youxia [1 ]
Zhang, Jiefang [1 ]
Qi, Lin [1 ]
Dong, Yiming [1 ]
Zhou, Haixia [2 ]
Li, Yuan [1 ]
机构
[1] Hebei Med Univ, Dept Gen Internal Med, Hosp Shijiazhuang 4, Maternal Hosp, Shijiazhuang 050031, Hebei, Peoples R China
[2] Hebei Med Univ, Dept Diagnost Ultrasound, Hosp Shijiazhuang 4, Maternal Hosp, Shijiazhuang 050031, Hebei, Peoples R China
关键词
GDM; NO; ET-1; FMD; Patients;
D O I
10.1016/j.steroids.2022.108993
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Gestational diabetes mellitus (GDM) is a common pregnancy-related disorder that pregnant women without diabetes develop glucose tolerance during pregnancy. Endothelial dysfunction is the early event of vascular complications of diabetes. However, the role of endothelial dysfunction in GDM remains unknown. In this study, we hypothesize that there is a correlation between endothelial dysfunction and GDM indexes in the patients. Methods: 96 GDM patients and 96 gestational week-matched healthy pregnancies with normal glucose tolerance were recruited in our study. The expressions of endothelial function markers, including nitride oxidase (NO) and endothelin-1 (ET-1), as well as flow-mediated dilatation (FMD), were measured. In addition, their correlation in GDM patients were also analyzed using Pearson's correlation analysis. Results: GDM patients displayed decrease on FMD and serum NO levels with an increase on serum ET-1 secretion in comparison with normal glucose tolerance group. ROC analysis identified the predictive value of FMD, ET-1 and NO for GDM. Furthermore, endothelial dysfunction was correlated with both fasting plasma glucose and plasma glucose levels after 1 h or 2 h of oral glucose tolerance test in GDM patients. Conclusion: Our data indicated that endothelial dysfunction was associated with GDM, and these markers might serve as potential biomarkers for GDM.
引用
收藏
页数:5
相关论文
共 17 条
[1]   Gestational diabetes mellitus [J].
Alfadhli, Eman M. .
SAUDI MEDICAL JOURNAL, 2015, 36 (04) :399-406
[2]   Endothelin: 30 Years From Discovery to Therapy [J].
Barton, Matthias ;
Yanagisawa, Masashi .
HYPERTENSION, 2019, 74 (06) :1232-1265
[3]   Flow-mediated dilation shows impaired endothelial function in patients with mastocytosis [J].
Bucci, Tommaso ;
Parente, Roberta ;
De Feo, Giulia ;
Cardamone, Chiara ;
Triggiani, Massimo .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (04) :1106-1111
[4]   Gestational diabetes mellitus: an updated overview [J].
Chiefari, E. ;
Arcidiacono, B. ;
Foti, D. ;
Brunetti, A. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2017, 40 (09) :899-909
[5]   Gestational Diabetes Mellitus [J].
Coustan, Donald R. .
CLINICAL CHEMISTRY, 2013, 59 (09) :1310-1321
[6]   Biomarkers of endothelial dysfunction in relation to impaired carbohydrate metabolism following pregnancy with gestational diabetes mellitus [J].
Goebl, Christian S. ;
Bozkurt, Latife ;
Yarragudi, Rajashri ;
Prikoszovich, Thomas ;
Tura, Andrea ;
Pacini, Giovanni ;
Koppensteiner, Renate ;
Kautzky-Willer, Alexandra .
CARDIOVASCULAR DIABETOLOGY, 2014, 13
[7]   Endothelin-1 Overexpression Exaggerates Diabetes-Induced Endothelial Dysfunction by Altering Oxidative Stress [J].
Idris-Khodja, Noureddine ;
Ouerd, Sofiane ;
Mian, Muhammad Oneeb Rehman ;
Gornitsky, Jordan ;
Barhoumi, Tlili ;
Paradis, Pierre ;
Schiffrin, Ernesto L. .
AMERICAN JOURNAL OF HYPERTENSION, 2016, 29 (11) :1245-1251
[8]   Mechanisms of ET-1-induced endothelial dysfunction [J].
Iglarz, Marc ;
Clozel, Martine .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 50 (06) :621-628
[9]   Gestational Diabetes Mellitus: Mechanisms, Treatment, and Complications [J].
Johns, Emma C. ;
Denison, Fiona C. ;
Norman, Jane E. ;
Reynolds, Rebecca M. .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2018, 29 (11) :743-754
[10]   The importance of endothelin-1 for microvascular dysfunction in diabetes [J].
Kalani, Majid .
VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (05) :1061-1068